It has long been believed that low testosterone levels could help to protect a man from developing prostate cancer. Furthermore, many doctors believed that giving a man with undetected prostate cancer Testosterone Replacement Therapy would ultimately worsen his condition. It was not until recently that many doctors began to see these beliefs for the myths that they are.
While it was medically proven a long time ago that low testosterone levels actually increase the risk of a man developing prostate cancer, it can take a long time to expel a widely accepted myth such as the one discussed above.
If you are struggle to accept the fact that low T-levels can increase your chances of developing prostate cancer, take a moment to consider the research of Dr. Abraham Morgentaler. As part of his research Dr. Morgentaler looked at every study ever published on the topic of of prostate cancer and hormone levels. Additionally, Dr. Morgentaler performed several studies of his own. Through this research he established several key facts.
-Low testosterone levels do not protect against prostate cancer. In fact, they can increase your risk.
-High levels of testosterone in the blood do not increase your chances of developing prostate cancer.
-The use of Testosterone Replacement Therapy did not increase the risk of developing prostate cancer, even in men with a high risk of developing this cancer.
Still not ready to abandon the myth that high testosterone levels can increase your risk of prostate cancer? Take a moment to think about this. Prostate cancer rarely affects men in their 20’s. However, this is when men experience a natural height in their testosterone production. If high testosterone levels resulted in a higher risk of prostate cancer, men would be at a higher risk of developing this disease in their youth rather than as they age.
Wondering where this wide spread myth started? Well you may be surprised to learn that this myth started as the result of a 1941 study conducted by Dr. Higgins. This study consisted of only three men, but only reported on the findings of two men. To make matters worse, one of the men included in the study had been previously castrated.
When challenging this controversial study, many doctors will also refer to another old study published in 1981 which backed up the findings of Dr. Higgins. While this study did make use of more participants, only four of the men who participated in the study had not received some type of prior hormone treatment. These treatments included castration and estrogen. Furthermore, all four of these men responded positively to the use of Testosterone Replacement Therapy.
At the conclusion of his research, Dr. Morgentaler found that no published studies to date could demonstrate a direct relationship between high testosterone levels and an increased risk of prostate cancer.
In 2006, Dr. Morgentaler teamed up with Dr. Rhoden to conduct another study on the topic. The findings of this study were concurrent with his previous studies, ultimately showing that men with lower testosterone levels were at a higher risk of developing prostate cancer. Studies conducted by other doctors all over the world have continuously backed up these findings. Unfortunately, despite the overwhelming medical facts, there are still many patients and doctors who hold onto the old myth that TRT can increase the risk of prostate cancer. Through the use of successful therapy and public education, we hope to change that in the near future.